Acelyrin Inc. (NASDAQ:SLRN) finished Wednesday with a subtraction of -$0.68 to close at $24.82, a downside of -2.67 percent. An average of 682,197 shares of common stock have been traded in the last five days. There was a gain of $0.66 in the past week. The last 20 days have seen an average of 593,299 shares traded, while the 50-day average volume stands at 697,920.
SLRN stock has increased by 20.60% in the last month. The company shares reached their 1-month lowest point of $19.32 on 07/11/23. Shares of the company touched a low of $16.60 and a high of $26.02 in 52 weeks. In spite of this, the price is down -4.61% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
The quick ratio of Acelyrin Inc. for the three months ended March 30 was 8.70, and the current ratio was 8.70, indicating that the company is able to meet its debt obligations.
Earnings Surprise
The analyst consensus anticipated Acelyrin Inc.’s latest quarter earnings to come in at -$10.89 per share, but it turned out to be -$8.61, a 20.90% surprise. Shareholders own equity worth $97.2 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Acelyrin Inc. (SLRN) price momentum. RSI 9-day as of the close on 09 August was 57.15%, suggesting the stock is Neutral, with historical volatility in this time frame at 40.71%.
As of today, SLRN’s price is $24.68 +2.75% or $0.66 from its 5-day moving average. SLRN is currently trading +20.43% higher than its 20-day SMA. However, the stock’s current price level is +35.61% above the SMA50.
The stochastic %K and %D were 72.20% and 70.20%, respectively, and the average true range (ATR) was 1.38. With the 14-day stochastic at 60.23% and the average true range at 1.39, the RSI (14) stands at 58.44%. The stock has reached 0.24 on the 9-day MACD Oscillator while the 14-day reading was at 0.40.
Analyst Ratings
TD Cowen launched coverage on Acelyrin Inc. (NASDAQ: SLRN) in its analyst report released on May 30, 2023. The firm assigned the stock an Outperform rating. The consensus rating for Acelyrin Inc. (SLRN) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell SLRN, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 4 others rate it as a “buy”.
